GLPBio

Signaling Pathways

Research Area, Signaling Pathways | GlpBio Life Science Products Suppliers

Read More about this category

The antibody-drug conjugate (ADC), a humanized or human monoclonal antibody conjugated with highly cytotoxic small molecules (payloads) through chemical linkers, is a novel therapeutic format and has great potential to make a paradigm shift in cancer chemotherapy. The three components of the ADC together give rise to a powerful oncolytic agent capable of delivering normally intolerable cytotoxins directly to cancer cells, which then internalize and release the cell-destroying drugs. At present, two ADCs, Adcetris and Kadcyla, have received regulatory approval with >40 others in clinical development.

ADCs are administered intravenously in order to prevent the mAb from being destroyed by gastric acids and proteolytic enzymes. The mAb component of the ADC enables it to circulate in the bloodstream until it finds and binds to tumor-specific cell surface antigens present on target cancer cells. Linker chemistry is an important determinant of the safety, specificity, potency and activity of ADCs. Linkers are designed to be stable in the blood stream (to conform to the increased circulation time of mAbs) and labile at the cancer site to allow rapid release of the cytotoxic drug. First generation ADCs made use of early cytotoxins such as the anthracycline, doxorubicin or the anti-metabolite/antifolate agent, methotrexate. Current cytotoxins have far greater potency and can be divided into three main groups: auristatins, maytansines and calicheamicins.

The development of site-specific conjugation methodologies for constructing homogeneous ADCs is an especially promising path to improving ADC design, which will open the way for novel cancer therapeutics.

References:

[1] Tsuchikama K, et al. Protein Cell. 2016 Oct 14. DOI:10.1007/s13238-016-0323-0.

[2] Peters C, et al. Biosci Rep. 2015 Jun 12;35(4). pii: e00225. doi: 10.1042/BSR20150089.

Research Areas

Products Related to Signaling Pathways(40699)

  • GC91624 structure
    GC916247-PPD-Q
    CAS: 2894124-00-4
    Purity: >95.00%

    7-PPD-Q is an oxidized derivative of the tire antiozonant and a substituted p-phenylenediamine 7-PPD.

  • GC91627 structure
    GC91627Semaglutide (sodium salt)
    CAS: 2924330-56-1
    Purity: >98.00%

    Semaglutide is an agonist of glucagon-like peptide 1 receptor (GLP-1R; EC50 = 6.2 pM in a reporter assay using BHK cells expressing the human receptor).

  • GC91629 structure
    GC91629OPPD-Q
    CAS: 2952779-34-7
    Purity: >98.00%

    OPPD-Q is a p-phenylenediamine-quinone (PPD-Q) and an oxidized derivative of the aromatic amine antioxidant OPPD .

  • GC91632 structure
    GC91632Verrucarin H
    CAS: 29953-50-2
    Purity: >70.00%

    Verrucarin H is a macrocyclic trichothecene mycotoxin that has been found in M. verrucaria.

  • GC91634 structure
    GC91634ARN25062
    CAS: 3036492-85-7
    Purity: >95.00%

    ARN25062 is a derivative of ARN22089, an inhibitor of the protein-protein interaction between Cdc42 and p21-activated kinase (PAK).

  • GC91639 structure
    GC91639Ferrous trisglycinate
    CAS: 34369-82-9
    Purity: >95.00%

    Ferrous trisglycinate is an iron amino acid chelate.

  • GC91647 structure
    GC91647Perfluoropropanesulfonic Acid
    CAS: 423-41-6
    Purity: >90.00%

    Perfluoropropanesulfonic acid is a perfluoroalkyl substance (PFAS).

  • GC91648 structure
    GC91648Akt-I-1
    CAS: 473382-39-7
    Purity: >98.00%

    Akt-I-1 is an inhibitor of Akt1 (IC50 = 4.6 µM).

  • GC91650 structure
    GC916502-(Morpholin-4-yl)ethane-1-sulfonamide
    CAS: 4945-80-6
    Purity: >98.00%

    2-(Morpholin-4-yl)ethane-1-sulfonamide is a byproduct in the synthesis of diazo compounds.

  • GC91655 structure
    GC91655N-Methylnuciferine (iodide)
    CAS: 53098-68-3
    Purity: >98.00%

    N-Methylnuciferine is an aporphine alkaloid that has been found in A. cherimola and has diverse biological activities.

  • GC91658 structure
    GC916588(Z),11(Z),14(Z)-Heptadecatrienal
    CAS: 56797-44-5
    Purity: >98.00%

    8(Z),11(Z),14(Z)-Heptadecatrienal is a polyunsaturated fatty aldehyde.

  • GC91659 structure
    GC91659BDW-OH
    CAS: 573976-22-4
    Purity: >95.00%

    BDW-OH is an active metabolite of the STING agonist and prodrug BDW568 .

  • GC91660 structure
    GC91660Alborixin
    CAS: 57760-36-8
    Purity: >70.00%

    Alborixin is an ionophore originally isolated from S. albus that has diverse biological activities.

  • GC91667 structure
    GC91667NSC 44625
    CAS: 654-62-6
    Purity: >98.00%

    NSC 44625 is an inhibitor of carbonic anhydrase II (CAII; Ki = 63 nM for the human enzyme).

  • GC91669 structure
    GC91669m-isobutyl Ibuprofen
    CAS: 66622-47-7
    Purity: >98.00%

    m-isobutyl Ibuprofen is a potential impurity in commercial preparations of the non-steroidal anti-inflammatory drug (NSAID) and COX inhibitor ibuprofen.

  • GC91670 structure
    GC91670MRSA Antibiotic 1
    CAS: 667410-81-3
    Purity: >95.00%

    MRSA antibiotic 1 is an antibiotic.

  • GC91672 structure
    GC91672IPPD-Q
    CAS: 68054-73-9
    Purity: >98.00%

    IPPD-Q는 N,N'-Substituted p-phenylenediamines (PPD)의 산화 생성물로 디티오들글리톨(DTT) 소비율에 대한 산화 잠재력 값이 0.93μM min–1μM–1이다. IPPD-Q는 대기오염 연구와 오염물질 진단 연구에 사용되었다.

  • GC91673 structure
    GC91673CPPD-Q
    CAS: 68054-78-4
    Purity: >98.00%

    CPPD-Q is an oxidized derivative of the antioxidant CPPD, possessing antibacterial and insecticidal effects.

  • GC91675 structure
    GC91675Artepillin C
    CAS: 72944-19-5
    Purity: >95.00%

    Artepillin C is a prenylated cinnamic acid that has been found in B. grisebachii and has diverse biological activities.

  • GC91680 structure
    GC916804-Acetamido Antipyrine
    CAS: 83-15-8
    Purity: >95.00%

    4-Acetamido antipyrine (4-AAAP) is an active metabolite of the non-opioid analgesic and antipyretic prodrug metamizole .

  • GC91681 structure
    GC91681Loxoprofen-SRS
    CAS: 83648-76-4
    Purity: >98.00%

    Loxoprofen-SRS is a non-steroidal anti-inflammatory drug (NSAID) and COX inhibitor (IC50s = 0.5 and 0.39 for recombinant human COX-1 and COX-2, respectively) and an active metabolite of the prodrug loxoprofen .

  • GC91688 structure
    GC91688PDIC-NN
    CAS: 932740-48-2
    Purity: >95.00%

    PDIC-NN is an intermediate in the synthesis of PDIC-NS , an activator of stimulator of interferon genes (STING) with anticancer activity.

  • GC91689 structure
    GC91689TG46
    CAS: 936091-15-5
    Purity: >98.00%

    TG46 is an inhibitor of JAK2 (IC50 = 12.5 µM).

  • GC91690 structure
    GC91690TASP0277308
    CAS: 945725-50-8
    Purity: >98.00%

    TASP0277308 is a sphingosine-1-phosphate receptor 1 (S1P1) antagonist (IC50 = 4.2 nM).